Compounds > 3',4',5'-O-trimethyltricetin
Page last updated: 2024-08-01 18:15:49

3',4',5'-O-trimethyltricetin

Description

3',4',5'-O-trimethyltricetin : A trimethoxyflavone that is the 3',4',5'-tri-O-methyl ether of tricetin. [CHeBI]

Cross-References

ID SourceID
PubMed CID5379265
CHEMBL ID486590
SCHEMBL ID4918477
CHEBI ID543745

Synonyms (45)

Synonym
nsc-123410
4h-1-benzopyran-4-one,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-
5,4',5'-trimethoxyflavone
nsc123410
mls002707300 ,
5,4',5'-trimethoxy flavone
flavone,7-dihydroxy-3',4',5'-trimethoxy-
18103-42-9
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4h-chromen-4-one
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-
flavone, 5,7-dihydroxy-3',4',5'-trimethoxy-
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one
5,7-dihydroxy-3',4',5'-trimethoxy flavone
5, 7-dihydroxy-3',4',5'-trimethoxyflavone
5,7-dihydroxy-3',4',5'-trimethoxyflavon
smr001574694
CHEMBL486590
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4h-1-benzopyran-4-one
tricetin 3',4',5'-trimethyl ether
3',4',5'-o-trimethyltricetin
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4-benzopyrone
CHEBI:543745 ,
5,7-dihydroxy-3',4',5'-trimethoxyflavone
LMPK12110880
2j9jj5n2h7 ,
nsc 123410
tricin 4'-methyl ether
einecs 242-001-0
unii-2j9jj5n2h7
C19807
mfcd00016924
SCHEMBL4918477
AKOS025287600
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4h-chromen-4-one #
CPCPHNWWTJLXKQ-UHFFFAOYSA-N
DTXSID70171059
5-7-dihydroxy-3-4-5-trimethoxyflavone
flavone, 5,7-dihydroxy-3',4',5'-trimethoxy- (8ci)
5,7-dihydroxy-3',4',5'-trimethoxy-flavone
FS-8799
FT-0756628
Q27105170
XD161933
5,7-dihydroxy-3?,4?,5?-trimethoxyflavone
3',4',5'-tri-o-methyl-tricetin

Drug Classes (3)

ClassDescription
trimethoxyflavoneA methoxyflavone that is flavone substituted by three methoxy groups.
dihydroxyflavoneAny hydroxyflavone in which two ring hydrogens are replaced by hydroxy substituents.
3',5'-dimethoxyflavoneA dimethoxyflavone in which the hydroxy groups at positions 3' and 5' have been replaced by methoxy groups.

Bioassays (10)

Assay IDTitleYearJournalArticle
AID403036Cytotoxicity against human NCI-H460 cells at 58 uM2005Journal of natural products, Aug, Volume: 68, Issue:8
ISSN: 0163-3864		Constituents of Vittaria anguste-elongata and their biological activities.
AID404069In vivo antitumor activity against mouse L1210 cellsJournal of natural products, , Volume: 42, Issue:1
ISSN: 0163-3864		Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones.
AID403037Cytotoxicity against human SF268 cells at 58 uM2005Journal of natural products, Aug, Volume: 68, Issue:8
ISSN: 0163-3864		Constituents of Vittaria anguste-elongata and their biological activities.
AID400607Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells1996Journal of natural products, Mar, Volume: 59, Issue:3
ISSN: 0163-3864		Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID356482Antihistaminic activity in rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced beta-hexosaminidase release preincubated for 10 mins before DNP-BSA challenge2003Journal of natural products, Sep, Volume: 66, Issue:9
ISSN: 0163-3864		Tricin from a malagasy connaraceous plant with potent antihistaminic activity.
AID356483Cytotoxicity against rat RBL2H3 cells at 500 uM by optical microscope2003Journal of natural products, Sep, Volume: 66, Issue:9
ISSN: 0163-3864		Tricin from a malagasy connaraceous plant with potent antihistaminic activity.
AID1434690Inhibition of sucrose loaded POPC/POPE/POPS/PtdIns(3,4,5)P3 (59:20:20:1) liposome binding to eGFP-fused PDK1 PH domain (unknown origin) expressed in Escherichia coli BL21 at 20 uM after 10 mins by fluorescence spectrophotometry based pull down assay relat2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
ISSN: 1464-3405		Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
ISSN: 1552-4922		Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
ISSN: 1557-8127		High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
ISSN: 1552-4922		Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
ISSN: 1557-8127		High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
ISSN: 1552-4922		Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
ISSN: 1557-8127		High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
xanthomicrol
0
dihydroxyflavone;
trimethoxyflavone		antineoplastic agent;
plant metabolite		00low000000
eupatorin
0
dihydroxyflavone;
polyphenol;
trimethoxyflavone		anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
Brassica napus metabolite;
calcium channel blocker;
P450 inhibitor;
vasodilator agent		00low000000
nevadensin
0
dihydroxyflavone;
trimethoxyflavone		plant metabolite00low000000
salvigenin
0
monohydroxyflavone;
trimethoxyflavone		antilipemic drug;
antineoplastic agent;
apoptosis inhibitor;
autophagy inducer;
hypoglycemic agent;
immunomodulator;
neuroprotective agent;
plant metabolite		00low000000
cirsilineol
0
dihydroxyflavone;
trimethoxyflavone		antineoplastic agent;
plant metabolite		00low000000
chrysosplenol c
0
trihydroxyflavone;
trimethoxyflavone		antineoplastic agent;
antiviral agent;
plant metabolite		00low000000
2-(4-hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one
0
monohydroxyflavone;
trimethoxyflavone		00low000000
5,6,7-trimethoxyflavone
0
trimethoxyflavoneanti-HSV-1 agent;
plant metabolite		00low000000
eupatilin
0
dihydroxyflavone;
trimethoxyflavone		anti-inflammatory agent;
anti-ulcer drug;
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
metabolite		00low000000
ayanin
0
dihydroxyflavone;
trimethoxyflavone		plant metabolite00low000000
dexmedetomidine
0
trihydroxyflavone;
trimethoxyflavone		antineoplastic agent;
metabolite		00low000000
pachypodol
0
dihydroxyflavone;
trimethoxyflavone		antiemetic;
plant metabolite		00low000000
santin
0
dihydroxyflavone;
trimethoxyflavone		plant metabolite00low000000
centaureidin
0
trihydroxyflavone;
trimethoxyflavone		antineoplastic agent;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
plant metabolite		00low000000
eupatin
0
flavonols;
trihydroxyflavone;
trimethoxyflavone		00low000000
7,8-dihydroxyflavone
0
dihydroxyflavoneantidepressant;
antineoplastic agent;
antioxidant;
plant metabolite;
tropomyosin-related kinase B receptor agonist		00low000000
baicalin
0
dihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative		antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug		00low000000
swertisin
0
dihydroxyflavone;
flavone C-glycoside;
monomethoxyflavone;
monosaccharide derivative;
polyphenol		adenosine A1 receptor antagonist;
anti-inflammatory agent;
antioxidant;
hypoglycemic agent;
plant metabolite		00low000000
skullcapflavone ii
0
dihydroxyflavone;
tetramethoxyflavone		anti-asthmatic drug;
plant metabolite		00low000000
spinosin
0
dihydroxyflavone;
flavone C-glycoside;
monomethoxyflavone		anxiolytic drug;
plant metabolite		00low000000
4',6-dihydroxyflavone
0
dihydroxyflavone00low000000
cirsimaritin
0
dihydroxyflavone;
dimethoxyflavone		00low000000
4',6-dihydroxy-5,7-dimethoxyflavone
0
dihydroxyflavone;
dimethoxyflavone		00low000000
saponarin
0
C-glycosyl compound;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative		metabolite00low000000
6-prenylchrysin
0
7-hydroxyflavonol;
dihydroxyflavone		00low000000
sideroxylin
0
dihydroxyflavone;
monomethoxyflavone		plant metabolite00low000000
ladanein
0
dihydroxyflavone;
dimethoxyflavone		antiviral agent;
plant metabolite;
radical scavenger		00low000000
acacetin
0
dihydroxyflavone;
monomethoxyflavone		anticonvulsant;
plant metabolite		00low000000
apigetrin
0
beta-D-glucoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative		antibacterial agent;
metabolite;
non-steroidal anti-inflammatory drug		00low000000
apiin
0
beta-D-glucoside;
dihydroxyflavone;
glycosyloxyflavone		EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
plant metabolite		00low000000
chrysin
0
7-hydroxyflavonol;
dihydroxyflavone		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor;
hepatoprotective agent;
plant metabolite		00low000000
chrysosplenetin b
0
dihydroxyflavone;
tetramethoxyflavone		antiviral agent;
plant metabolite		00low000000
genkwanin
0
dihydroxyflavone;
monomethoxyflavone		metabolite00low000000
robinin
0
dihydroxyflavone;
glycosyloxyflavone		plant metabolite00low000000
wogonin
0
dihydroxyflavone;
monomethoxyflavone		angiogenesis inhibitor;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
plant metabolite		00low000000
4',7-dihydroxyflavone
0
dihydroxyflavonemetabolite00low000000
rhoifolin
0
dihydroxyflavone;
glycosyloxyflavone;
neohesperidoside		metabolite00low000000
alvocidib
0
dihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound		antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor		00low000000
casticin
0
dihydroxyflavone;
tetramethoxyflavone		apoptosis inducer;
plant metabolite		00low000000
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
0
dihydroxyflavone;
monomethoxyflavone		antineoplastic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor		00low000000
5,7-dihydroxy-4',6-dimethoxyflavone
0
dihydroxyflavone;
dimethoxyflavone		plant metabolite00low000000
ermanin
0
dihydroxyflavone;
dimethoxyflavone		anti-inflammatory agent;
antimycobacterial drug;
antineoplastic agent;
apoptosis inducer;
plant metabolite		00low000000
5,4'-dihydroxy-7,3'-dimethoxyflavone
0
dihydroxyflavone;
dimethoxyflavone		anti-allergic agent;
anti-inflammatory agent;
antibacterial agent;
antioxidant;
melanin synthesis inhibitor;
plant metabolite		00low000000
lespenefril
0
alpha-L-rhamnoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative;
polyphenol		anti-inflammatory agent;
antidepressant;
antineoplastic agent;
apoptosis inducer;
bone density conservation agent;
hypoglycemic agent;
immunomodulator;
plant metabolite		00low000000
syringetin
0
3',5'-dimethoxyflavone;
3'-methoxyflavones;
7-hydroxyflavonol;
dimethoxyflavone;
tetrahydroxyflavone		metabolite;
platelet aggregation inhibitor		00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
naringenin
1
4'-hydroxyflavanones;
trihydroxyflavanone		201720177.0low000010
flavone
2
flavonesmetabolite;
nematicide		1996201717.5low001010
eriodictyol
1
flavanones201720177.0medium000010
d-alpha tocopherol
1
alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite		2005200519.0low000100
cromolyn sodium
1
organic sodium saltanti-asthmatic drug;
drug allergen		2003200321.0low000100
tangeretin
2
pentamethoxyflavoneantineoplastic agent;
plant metabolite		1996200324.5low001100
hesperetin
1
3'-hydroxyflavanones;
4'-methoxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone		antineoplastic agent;
antioxidant;
plant metabolite		1996199628.0low001000
homoeriodictyol
1
3'-methoxyflavanones;
4'-hydroxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone		flavouring agent;
metabolite		1996199628.0low001000
umuhengerin
1
1996199628.0medium001000
4'-methoxyflavone
1
ether;
flavonoids		1996199628.0low001000
5,7-dimethoxyflavone
1
dimethoxyflavoneplant metabolite201720177.0low000010
4',5,6,7-tetramethoxyflavone
1
tetramethoxyflavoneantimutagen;
plant metabolite		201720177.0low000010
eupatorin
1
dihydroxyflavone;
polyphenol;
trimethoxyflavone		anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
Brassica napus metabolite;
calcium channel blocker;
P450 inhibitor;
vasodilator agent		1996199628.0low001000
karanjin
1
extended flavonoid1996199628.0low001000
daidzin
1
7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative		plant metabolite1996199628.0low001000
sinensetin
1
pentamethoxyflavoneplant metabolite1996199628.0low001000
sideritoflavone
1
ether;
flavonoids		2003200321.0high000100
isosakuranetin
1
(2S)-flavan-4-one;
4'-methoxyflavanones;
dihydroxyflavanone;
monomethoxyflavanone		plant metabolite1996199628.0low001000
cirsimaritin
1
dihydroxyflavone;
dimethoxyflavone		2003200321.0low000100
pinocembrin
1
201720177.0medium000010
sakuranetin
1
201720177.0medium000010
5,7-dimethoxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one
1
ether;
flavonoids		201720177.0medium000010
naringenin
1
(2S)-flavan-4-one;
naringenin		expectorant;
plant metabolite		1996199628.0low001000
taxifolin
1
taxifolinmetabolite1996199628.0low001000
isonaringin
1
(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
rutinoside		anti-inflammatory agent;
antioxidant;
metabolite		1996199628.0low001000
3',4'-dimethoxyflavone
1
2003200321.0low000100
silybin
1
1996199628.0low001000
alpinetin
1
ether;
flavonoids		201720177.0low000010
quercetin
2
7-hydroxyflavonol;
pentahydroxyflavone		antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger		1996201717.5low001010
acacetin
1
dihydroxyflavone;
monomethoxyflavone		anticonvulsant;
plant metabolite		1996199628.0low001000
apigenin
3
trihydroxyflavoneantineoplastic agent;
metabolite		1996201718.7low001110
luteolin
3
3'-hydroxyflavonoid;
tetrahydroxyflavone		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist		1996201718.7low001110
gossypetin
1
7-hydroxyflavonol;
hexahydroxyflavone		plant metabolite201720177.0low000010
chrysoeriol
1
monomethoxyflavone;
trihydroxyflavone		antineoplastic agent;
antioxidant;
metabolite		1996199628.0low001000
rutin
1
disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone		antioxidant;
metabolite		1996199628.0low001000
kaempferol
1
7-hydroxyflavonol;
flavonols;
tetrahydroxyflavone		antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite		1996199628.0low001000
amentoflavone
1
biflavonoid;
hydroxyflavone;
ring assembly		angiogenesis inhibitor;
antiviral agent;
cathepsin B inhibitor;
P450 inhibitor;
plant metabolite		1996199628.0low001000
baicalein
2
trihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger		1996200324.5low001100
chrysin
3
7-hydroxyflavonol;
dihydroxyflavone		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor;
hepatoprotective agent;
plant metabolite		1996201718.7low001110
datiscetin
2
7-hydroxyflavonol;
tetrahydroxyflavone		1996201717.5medium001010
diosmetin
2
3'-hydroxyflavonoid;
monomethoxyflavone;
trihydroxyflavone		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
bone density conservation agent;
cardioprotective agent;
plant metabolite;
tropomyosin-related kinase B receptor agonist;
vasodilator agent		1996201717.5low001010
fisetin
2
3'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite		1996201717.5low001010
galangin
2
7-hydroxyflavonol;
trihydroxyflavone		antimicrobial agent;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
plant metabolite		1996201717.5low001010
genkwanin
1
dihydroxyflavone;
monomethoxyflavone		metabolite201720177.0low000010
hinokiflavone
1
aromatic ether;
biflavonoid;
hydroxyflavone		antineoplastic agent;
metabolite;
neuroprotective agent		1996199628.0low001000
3-methylquercetin
1
7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone		anticoagulant;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite		1996199628.0low001000
kaempferide
1
7-hydroxyflavonol;
monomethoxyflavone;
trihydroxyflavone		antihypertensive agent;
metabolite		1996199628.0low001000
morin
2
7-hydroxyflavonol;
pentahydroxyflavone		angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent		1996201717.5low001010
myricetin
2
7-hydroxyflavonol;
hexahydroxyflavone		antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite		1996201717.5low001010
norwogonin
1
trihydroxyflavoneantioxidant;
metabolite		201720177.0low000010
quercetagetin
1
flavonols;
hexahydroxyflavone		antioxidant;
antiviral agent;
plant metabolite		1996199628.0low001000
rhamnetin
1
monomethoxyflavone;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
metabolite		1996199628.0low001000
robinetin
1
7-hydroxyflavonol;
pentahydroxyflavone		plant metabolite1996199628.0low001000
sciadopitysin
1
biflavonoid;
hydroxyflavone;
methoxyflavone;
ring assembly		bone density conservation agent;
platelet aggregation inhibitor		1996199628.0low001000
scutellarein
2
tetrahydroxyflavonemetabolite2003201714.0low000110
tamarixetin
1
7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone		antioxidant;
metabolite		1996199628.0low001000
tricetin
1
pentahydroxyflavoneantineoplastic agent;
metabolite		201720177.0low000010
tricin
1
3'-methoxyflavones;
dimethoxyflavone;
trihydroxyflavone		EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite		2003200321.0low000100
daidzein
1
7-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite		1996199628.0low001000
psi-baptigenin
1
7-hydroxyisoflavones;
benzodioxoles		antiprotozoal drug;
plant metabolite		1996199628.0low001000
syringetin
2
3',5'-dimethoxyflavone;
3'-methoxyflavones;
7-hydroxyflavonol;
dimethoxyflavone;
tetrahydroxyflavone		metabolite;
platelet aggregation inhibitor		1996201717.5medium001010
tectochrysin
1
monohydroxyflavone;
monomethoxyflavone		antidiarrhoeal drug;
antineoplastic agent;
plant metabolite		1996199628.0low001000
4',7-dihydroxyflavone
1
dihydroxyflavonemetabolite201720177.0low000010
astragalin
1
beta-D-glucoside;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone		plant metabolite;
trypanocidal drug		1996199628.0low001000
3,3'-di-o-methylquercetin
1
3'-methoxyflavones;
dimethoxyflavone;
trihydroxyflavone		antibacterial agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite		1996199628.0medium001000
fustin
1
1996199628.0low001000
3',4'-didemethylnobiletin
1
2003200321.0low000100
isorhamnetin 3-o-glucoside
1
beta-D-glucoside;
glycosyloxyflavone;
monomethoxyflavone;
monosaccharide derivative;
trihydroxyflavone		metabolite1996199628.0low001000
tiliroside
1
cinnamate ester;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone		plant metabolite1996199628.0low001000
avicularin
1
alpha-L-arabinofuranoside;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone		hepatoprotective agent;
plant metabolite		1996199628.0low001000
eupatorin-5-methyl ether
1
1996199628.0high001000
dihydrorobinetin
1
1996199628.0high001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Inflammation0
1
2010201014.0high000100
Innate Inflammatory Response0
1
2010201014.0high000100
Leucocythaemia0
1
2003200321.0high000100
Leukemia0
1
2003200321.0high000100